BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31342368)

  • 1. Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 Breast Lesions.
    Laws A; Crocker A; Dort J; Olson D; Elwi A; Anderes S; Parker S; Estey A; Keehn A; Quan ML
    Ann Surg Oncol; 2019 Oct; 26(10):3361-3367. PubMed ID: 31342368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving breast diagnostic services with a Rapid Access Diagnostic and Support (RADS) program.
    Arnaout A; Smylie J; Seely J; Robertson S; Knight K; Shin S; Ramsey T; Mallick R; Watters J
    Ann Surg Oncol; 2013 Oct; 20(10):3335-40. PubMed ID: 23975290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" Algorithm.
    Alvarenga J; Moran J; Bulgaru A; Moran MS
    J Breast Imaging; 2022 Oct; 4(5):474-479. PubMed ID: 38416949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Observational Study to Compare the Role of Ultrasound with Mammography in Women Identified at High Risk for Breast Cancer in a Population in China.
    An P; Zhong S; Zhang R; Hou X; Xi R; Wang Y
    Med Sci Monit; 2020 Jun; 26():e919777. PubMed ID: 32576809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recall rate of screening ultrasound with automated breast volumetric scanning (ABVS) in women with dense breasts: a first quarter experience.
    Arleo EK; Saleh M; Ionescu D; Drotman M; Min RJ; Hentel K
    Clin Imaging; 2014; 38(4):439-444. PubMed ID: 24768327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of BI-RADS to interpret magnetic resonance mammography for breast cancer].
    Kharuzhyk SA; Shimanets SV; Karman AV; Shapoval EV
    Vestn Rentgenol Radiol; 2014; (4):46-59. PubMed ID: 25775888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of referring physician specialty and practice type on referral for image-guided breast biopsy.
    Lazarus E; Mainiero MB; Gareen IF
    J Am Coll Radiol; 2005 Jun; 2(6):488-93. PubMed ID: 17411865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women.
    Percac-Lima S; Ashburner JM; McCarthy AM; Piawah S; Atlas SJ
    J Womens Health (Larchmt); 2015 Feb; 24(2):138-43. PubMed ID: 25522246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Disparities in Breast Imaging Wait Times Before and After the Implementation of a Same-Day Biopsy Program.
    Yoon SC; Taylor-Cho MW; Charles MG; Grimm L
    J Breast Imaging; 2023 Mar; 5(2):159-166. PubMed ID: 38416937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.
    Palmieri FM; DePeri ER; Mincey BA; Smith JA; Wen LK; Chewar DM; Abaya R; Colon-Otero G; Perez EA
    Mayo Clin Proc; 2009 Apr; 84(4):317-22. PubMed ID: 19339648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
    Du YR; Wu Y; Chen M; Gu XG
    Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-calcified ductal carcinoma in situ of the breast: comparison of diagnostic accuracy of digital breast tomosynthesis, digital mammography, and ultrasonography.
    Su X; Lin Q; Cui C; Xu W; Wei Z; Fei J; Li L
    Breast Cancer; 2017 Jul; 24(4):562-570. PubMed ID: 27837442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
    Chikarmane SA; Tai R; Meyer JE; Giess CS
    Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
    Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
    Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronucleus Test for Diagnosing Uncertain Cases (BI-RADS 3) in Breast Cancer Screening: A Review and Preliminary Results.
    Menicagli R; Marotta O; Serra R
    Gulf J Oncolog; 2020 Jan; 1(32):45-50. PubMed ID: 32342918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided?
    Guo Y; Raghu M; Durand M; Hooley R
    Br J Radiol; 2018 Oct; 91(1090):20170816. PubMed ID: 29338316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.